Cardiovascular and antithrombotic therapy
Research activity includes apixaban formulations, with interest in anticoagulation and the prevention of thromboembolic events.
- Apixaban tablet formulations
- Anticoagulant treatment
- Thromboembolism
The sponsor’s clinical work in this area is centered on oral antithrombotic medicines and their therapeutic equivalence.
Psychiatry and antidepressant treatment
Clinical research also covers escitalopram products, reflecting interest in depression management and other mood disorder therapies.
- Escitalopram formulations
- Antidepressant therapy
- Depressive disorders
This area focuses on oral selective serotonin reuptake inhibitor medicines and formulation-based therapeutic access.
Bioequivalence and pharmaceutical formulation research
The sponsor funds studies comparing capsules, film-coated tablets, and other oral dosage forms to assess therapeutic comparability.
- Oral solid dosage forms
- Relative bioavailability
- Generic medicine development
These activities support evaluation of how different formulations perform in healthy volunteers under controlled conditions.
Healthy volunteer pharmacology
Current trials are conducted in healthy adults, with emphasis on oral administration and comparison of marketed and test formulations.
- Single-dose oral studies
- Fasting condition assessments
- Comparative pharmacokinetics
This research setting is used to examine formulation performance in a controlled clinical pharmacology environment.
